full2010.pdf - page 1219

1181
3.2) „µ¦š—°„µ¦¥n
°¥Å…¤´
œ
œÎ
µÂ‡š¸
Á¦¸
¥„¦—¨„˜·
„š¸É
‡´
—Á¨º
°„Å—o
š¸É
Á¨¸Ê
¥ŠÄœ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Á®¨ª MRS Áž}
œÁª¨µ 24
´É
ªÃ¤Š ¤µ…¸
—œ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°š¸É
Á˜·
¤ 1% Tributyrin ¨o
ªœÎ
µÅžn
¤š¸É
°»
–®£¼
¤·
37 °C Áž}
œÁª¨µ 48-72 ´É
ªÃ¤Š ™o
µ¤¸
„µ¦Äo
Ņ¤´
œ‹³Á„·
—ªŠÄ¦°Ç Ç蜸
(Michael and Pelezar, 1995)
3.3) „µ¦š—°„µ¦¥n
°¥Âžj
Š
œÎ
µÂ‡š¸
Á¦¸
¥„¦—¨„˜·
„š¸É
‡´
—Á¨º
°„Å—o
š¸É
Á¨¸Ê
¥ŠÄœ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Á®¨ª MRS Áž}
œÁª¨µ 24
´É
ªÃ¤Š ¤µ…¸
—œ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
° starch œÎ
µÅžn
¤š¸É
°»
–®£¼
¤·
37 °C Áž}
œÁª¨µ 48-72 ´É
ªÃ¤Š š—°„µ¦¥n
°¥Âžj
ŠÃ—¥
®¥—µ¦¨³¨µ¥Å°Ã°—¸
œ ™o
µ¤¸
„µ¦¥n
°¥¸
…°Š°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°‹³Å¤n
Áž¨¸É
¥œÁž}
œ¸
œÊÎ
µÁŠ·
œ (Michael and Pelezar, 1995)
4. „µ¦š—°ÂÂŸœ‡ªµ¤Åª…°ŠÁºÊ
°˜n
°¥µž’·
¸
ªœ³
œÎ
µÂ‡š¸
Á¦¸
¥„¦—¨„˜·
„š¸É
‡´
—Á¨º
°„Å—o
Á¨¸Ê
¥ŠÄœ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Á®¨ª MRS Áž}
œÁª¨µ 24 ´É
ªÃ¤Š…¸
—œ
°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Â…È
Š MRS n
ŠÁºÊ
°Áž}
œ 2 »
— ‡º
° »
—š¸É
1 Á„È
Äœ anaerobic jar n
¤š¸É
37 °C Áž}
œÁª¨µ 24 ´É
ªÃ¤Š »
—š¸É
2
n
¤š¸É
37 °C £µ¥Ä˜o
£µª³š¸É
¤¸
°µ„µ«Áž}
œÁª¨µ 24 ´É
ªÃ¤Š ˜¦ª‹—¼
„µ¦Á‹¦·
…°ŠÁºÊ
°œŸ·
ª®œo
µ°µ®µ¦š´Ê
Š 2 £µª³
5. „µ¦š—°ž¦³·
š›·
£µ¡„µ¦¥´
¥´Ê
Š„µ¦Á‹¦·
Ã—¥¥µž’·
¸
ªœ³
čo
cotton swab ™n
µ¥Â‡š¸
Á¦¸
¥„¦—¨„˜·
„š¸É
‡´
—Á¨º
°„Å—o
š¸É
Á¨¸Ê
¥ŠÄœ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Á®¨ª MRS Áž}
œÁª¨µ 18
´É
ªÃ¤Š ¨o
ªšÎ
µ„µ¦ž¦´
Ä®o
¤¸
‡ªµ¤…»n
œÁž}
œ 0.5 McFarland Ä®o
¤¸
‹Î
µœªœÁºÊ
° 10
8
CFU/ml œÎ
µÅžžj
µ¥ (swab) Ä®o
š´É
ª
Ÿ·
ª®œo
µ…°Š°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Â…È
Š MRS ¨o
ªž¨n
°¥Ä®o
®o
Š 3-5 œµš¸
‹µ„œ´Ê
œªµŠÂŸn
œ¥µ¤µ˜¦“µœ (antibiotic discs)
‹Î
µœªœ 15 œ·
— ŗo
„n
penicillin G (10 ôg), ampicillin (10 ôg), cephalothin (30 ôg), cefoperazone (75 ôg),
vancomycin (30 ôg) bacitracin (10 ôg), gentamicin (10 ôg), kanamycin (30 ôg), streptomycin (10 ôg), tetra-
cycline (30 ôg), chloramphenicol (30 ôg), erythromycin (15 ôg), norfloxacin (10 ôg) ¨³ polymyxin B (300 ôg)
ªµŠ¨Šœ¦·
Áª–š¸É
žj
µ¥ÁºÊ
°Åªo
(šÎ
µ 2 ŽÊÎ
µ) n
¤ÁºÊ
°š¸É
°»
–®£¼
¤·
37 °C Áž}
œÁª¨µ 24 ´É
ªÃ¤Š ¦µ¥ŠµœŸ¨Ã—¥„µ¦ª´
—Áo
œŸn
µœ
«¼
ϴr
„¨µŠ…°ŠªŠÄ (inhibition zone) ¨o
ªœÎ
µŸ¨š¸É
ŗo
¤µÁž¦¸
¥Áš¸
¥Á¡ºÉ
°—¼
ªn
µÁºÊ
°—´
Š„¨n
µª Ū (sensitive) ®¦º
°Ÿ¨„ÊÎ
µ„¹É
Š
(intermediate) ®¦º
°˜o
µœšµœ (resistant) ˜n
°¥µž’·
¸
ªœ³œ´Ê
ς
6. „µ¦š—°‡ªµ¤µ¤µ¦™…°ŠÂ‡š¸
Á¦¸
¥„¦—¨„˜·
„Äœ„µ¦¥´
¥´Ê
ŠÁº
Ê
°Â‡š¸
Á¦¸
¥n
Š¸Ê
Ĝ£µª³š¸É
Ťn
‹Î
µ„´
—
„¦—°·
œš¦¸
¥r
¨³Å±Ã—¦Á‹œÁž°¦r
°°„ÅŽ—r
×¥ª·
›¸
agar well diffusion
š—°„µ¦¥´
¥´Ê
ŠÃ—¥ª·
›¸
agar well diffusion ×¥œÎ
µÂ‡š¸
Á¦¸
¥n
Š¸Ê
Staphylococcus aureus
TISTR 517
¨³
Escherichia coli
TISTR 887 ¤µÁ¨¸Ê
¥ŠÄœ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Á®¨ª LB n
¤ÁºÊ
°š¸É
°»
–®£¼
¤·
37 °C Áž}
œÁª¨µ 24 ´É
ªÃ¤Š
œÎ
µÅžžj
µ¥ (swab) Ä®o
š´É
ªŸ·
ª®œo
µ…°Š°µ®µ¦Á¨¸Ê
¥ŠÁº
Ê
°Â…È
Š MHA ¨o
ªž¨n
°¥Ä®o
®o
Šš·Ê
ŠÅªo
3-5 œµš¸
‹µ„œ´Ê
œÁ‹µ³ª»o
œ
°µ®µ¦Ã—¥Äo
ž¨µ¥š·
žÂ¨³Á…¸É
¥ª»o
œ°°„ œÎ
µœÊÎ
µÁ¨¸Ê
¥ŠÁºÊ
°Â‡š¸
Á¦¸
¥„¦—¨„˜·
„š¸É
n
¤ÁºÊ
°Åªo
24 ´É
ªÃ¤Š 80 ŤÇ¦¨·
˜¦
®¥—¨ŠÄœ®¨»
¤š¸É
Á‹µ³Åªo
œ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Â…È
Š MRS ˜´Ê
Šš·Ê
ŠÅªo
Įo
®o
ŠÂ¨o
ªœÎ
µÅžn
¤ÁºÊ
°š¸É
°»
–®£¼
¤·
37 °C Áž}
œÁª¨µ 24
´É
ªÃ¤Š ˜¦ª‹Ÿ¨„µ¦¥´
¥´Ê
ŠÃ—¥—¼
‹µ„ªŠÄ…°Š„µ¦¥´
¥´Ê
Š (inhibition zone) (—´
—ž¨Š‹µ„ Spelhaug and Harlander,
1989)
Ÿ¨„µ¦ª·
‹´
¥Â¨³°£·
ž¦µ¥Ÿ¨
„µ¦Â¥„ÁºÊ
°Â‡š¸
Á¦¸
¥„¦—¨„˜·
〨o
Áž}
œÁºÊ
°š¸É
¦·
»
š›·Í
‡š¸
Á¦¸
¥„¦—¨„˜·
„š¸É
Â¥„Å—o
‹µ„˜Š„ªµÄ®o
Áž}
œÁºÊ
°¦·
»
š›·Í
‹µ„×¥ª·
›¸
„µ¦…¸
—ÁºÊ
°œ°µ®µ¦Á¨¸Ê
¥ŠÁºÊ
°Â…È
Š
MRS š¸É
Á˜·
¤ bromocresol purple 0.004% ŗo
Áž}
œÃ‡Ã¨œ¸
¤¸
¨´
„¬–³š¸É
˜„˜n
µŠ„´
œ Án
œ Ç蜸
„¨¤…°Á¦¸
¥®¦º
°®¥´
„
1...,1209,1210,1211,1212,1213,1214,1215,1216,1217,1218 1220,1221,1222,1223,1224,1225,1226,1227,1228,1229,...2023
Powered by FlippingBook